Literature DB >> 3241209

Ageing suppresses endothelium-dependent relaxation and generates contraction mediated by the muscarinic receptors in vascular smooth muscle of normotensive Wistar-Kyoto and spontaneously hypertensive rats.

T Koga1, Y Takata, K Kobayashi, S Takishita, Y Yamashita, M Fujishima.   

Abstract

We evaluated the effects of ageing and hypertension on endothelium-dependent relaxation and contraction of vascular smooth muscles. Aortic rings with and without endothelium from normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR), divided into young, adult and old groups, were examined for relaxation in response to acetylcholine, adenosine triphosphate (ATP) and sodium nitroprusside. Relaxation responses to acetylcholine and ATP in SHR were either equal to or greater than those in WKY. Relaxations induced by ATP were not altered by ageing, while the degree of acetylcholine-induced endothelium-dependent relaxations was in an inverse order of age in both SHR and WKY. In old SHR and WKY and adult SHR, lower doses of acetylcholine caused relaxations, but increases in the dose of acetylcholine induced contraction. Acetylcholine-induced contractions were abolished by indomethacin or endothelium rubbing. We conclude that endothelium-dependent relaxations are not diminished by spontaneous hypertension but the relaxations mediated by the muscarinic receptors are reduced with ageing. Further, acetylcholine causes endothelium-dependent contractions by releasing cyclo-oxygenase products, not only in SHR but also in aged normotensive WKY.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3241209     DOI: 10.1097/00004872-198812040-00073

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  12 in total

Review 1.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 2.  Vasoconstrictor prostanoids.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-24       Impact factor: 3.657

3.  Deletion of T-type calcium channels Cav3.1 or Cav3.2 attenuates endothelial dysfunction in aging mice.

Authors:  Anne D Thuesen; Kenneth Andersen; Kristina S Lyngsø; Mark Burton; Charlotte Brasch-Andersen; Paul M Vanhoutte; Pernille B L Hansen
Journal:  Pflugers Arch       Date:  2017-10-29       Impact factor: 3.657

Review 4.  Age-related changes in vascular smooth muscle and endothelium.

Authors:  Y Dohi; M Kojima; K Sato; T F Lüscher
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

5.  Effects of chronic and acute aminoguanidine treatment on tail artery vasomotion in ageing rats.

Authors:  A Tabernero; S Nadaud; B Corman; J Atkinson; C Capdeville-Atkinson
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Salicylate treatment improves age-associated vascular endothelial dysfunction: potential role of nuclear factor kappaB and forkhead Box O phosphorylation.

Authors:  Lisa A Lesniewski; Jessica R Durrant; Melanie L Connell; Brian J Folian; Anthony J Donato; Douglas R Seals
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-02-08       Impact factor: 6.053

7.  Lipoic acid significantly restores, in rats, the age-related decline in vasomotion.

Authors:  A R Smith; F Visioli; B Frei; T M Hagen
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

8.  Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat.

Authors:  F S Michel; G S Man; R Y K Man; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

9.  Age impairs Flk-1 signaling and NO-mediated vasodilation in coronary arterioles.

Authors:  Amanda J LeBlanc; Robert D Shipley; Lori S Kang; Judy M Muller-Delp
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-03       Impact factor: 4.733

Review 10.  Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors.

Authors:  Michel Félétou; Tony J Verbeuren; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2009-01-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.